ZENLABS logo

Zenlabs Ethica Ltd

ZENLABS·BSE·
₹29.85▲ +2.16 (+7.80%)
Market Cap17.81 Cr
PE Ratio-8.40
Volume607
Day High - Low31.00 - 27.00
52W High-Low39.99 - 16.50

Zenlabs Ethica Ltd (ZENLABS): company summary

The company's business is shrinking, with annual revenue falling 8.8% to ₹47 crore.

Zenlabs Ethica Ltd (ZENLABS) is a micro-cap Commercial Services company valued at ₹18 crore operating in Diversified Services on the NSE and BSE.

Recent price move
Zenlabs Ethica Ltd last traded at ₹29.85, sharply up 7.80% on the day.
Recent developments
On 2026-06-30, the company reported a net loss of ₹2 crore for its latest financial year, marking a swing from a net profit of ₹0 crore in the prior year. The latest quarter ended on 2026-06-30, with revenue rising 23.5% year-on-year to ₹14 crore, but net profit turned to a loss of ₹1 crore, down from a profit of ₹0 crore in the same quarter a year earlier.
Financial performance
The company's business is shrinking, with annual revenue falling 8.8% to ₹47 crore. The latest quarter saw revenue rise 23.5% year-on-year to ₹14 crore, but net profit swung to a loss of ₹1 crore, down from a profit of ₹0 crore in the same quarter a year earlier. Margins have deteriorated sharply, with the net profit margin at -4.1% compared to 0.5% a year ago, and returns remain negative.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 2.51 times book value.
Things to watch
The company is currently in a net loss, with a net profit margin of -4.1% and returns on equity and capital employed both negative. Revenue has declined over the past three years, with a compound annual growth rate of -11.2%, and the stock is 30.8% below its 52-week high. The company also carries debt of 1.22 times its equity.
Where it stands
Zenlabs Ethica Ltd ended its latest quarter with a net loss of ₹1 crore, while revenue rose 23.5% year-on-year to ₹14 crore. The company's net profit margin is -4.1%, and returns remain negative. The stock is 30.8% below its 52-week high, and the company reported a net loss of ₹2 crore for its latest financial year.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
2.1/10
Poor
Fair Value
Sign in to see
ROE
-22.73%
Weak
P/E
-8.40x
Loss-making
Debt / Equity
1.22
Elevated
Industry
Commercial Services
Diversified Services
Overall View
Poor

Price performance

Day₹27.00
₹31.00
52W₹16.50
₹39.99
DocStoX take

Supported by momentum (6.0), but held back by growth (0.0).

DocStoX score

Low confidence
2.1
/10
Poor
Quality
Weak
ROE -22.7%
Valuation
Fair
P/B 2.5× on assets (no earnings to value)
Growth
Flat
Revenue -3.7% 5Y CAGR
Risk
Elevated
D/E 1.22
Momentum
Firm
57% of 52-week range

At a glance

Market Cap
₹18 Cr
52W High / Low
₹40 / ₹17
Dividend Yield
0.76%
Promoter Holding
52.96%
EPS (TTM)
₹-2.97
Book Value
₹13.08

Key highlights

  • Loss-making — no meaningful P/E
  • Revenue shrinking 4% a year
0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Commercial Services stocks · Diversified Services

Zenlabs Ethica Ltd peers in Commercial Services

Other Commercial Services stocks on the NSE & BSE. See the full Commercial Services sector list.